Krsnaa Diagnostics Share Price

Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited at Pune, Maharashtra dated December 22, 2010. The Company name was changed to Krsnaa Diagnostics Private Limited, pursuant to a fresh Certificate of Incorporation issued by the RoC on January 29, 2015. Thereafter, the status got converted into a Public Company and the name was changed to Krsnaa Diagnostics Limited pursuant to a fresh Certificate of Incorporation issued by the RoC on 06 May, 2021. The Company is primarily engaged in providing diagnostic services centres all over India. The Company is providing Radiology and Pathology services for Xray, CT Scan, MRI, Mammography, Bone Densitometry, Ultrasound, Colout Doppler, TeleReporting services, all type of blood and urine investigation and other related diagnostic services. The Company owns an extensive network of integrated diagnostics centres across India primarily in nonmetro and lowertier cities and towns, with operating 1823 diagnostics centres offering radiology and pathology services in 13 states across the country. The Company started operating 12 centres in Himachal Pradesh via public private partnership (PPP) in 2012. It installed 50 centres in 2017 and expanded operations across 13 states in 2018. Further, it expanded the operations to over 1500 centres across India in 2020. The Company in August 2021, came up with an Initial Public Offer of 12,741,036 Equity Shares by raising funds from public aggregating to Rs.1213.33 Crore, comprising a Fresh Issue of 4,215,516 Equity Shares aggregating to Rs 400 Crore and an Offer for Sale of 8,525,520 Equity Shares aggregating to Rs. 813.33 Crore.The Company operationalized 26 radiology centers, 50 pathology labs, and 556 collection centers in 202223. It expanded geographical presence from 660+ centers in FY 2018 to over 2,800 centers in FY 2023. The Teleradiology hub in Pune achieved prestigious accreditationfrom the National Accreditation Board for Hospitals Healthcare Providers (NABH) during the year 2023. The Company expanded its geographical presence to more than 3600 centres in FY 2024. It expanded into Jharkhand with the launch of two new centres, by establishing over 600 collection centres in 2025. 40 CT scan units have been commissioned in Maharashtra, with MRI and additional CT installations in progress in FY 2025. In FY2025, retail operations were launched across four states and within a short span, the Companys network expanded from 1,600+ to over 2,400touchpoints. The Company acquired a 23.53% stake in Apulki Healthcare, making the Company an exclusive diagnostic partner with oncology and cardiac care hospitals in 2025.

Krsnaa Diagnostics reported a Q2 FY 2025-26 revenue of ₹205.99 crore, up 16.7% YoY, with net profit increased 36.5% to ₹23.94 crore. For the full year FY2025–2026, revenue reached ₹742.7 crore and profit touched at ₹77.61 crore. As of Sep '25, Krsnaa Diagnostics’s market capitalisation stood at ₹2,435.50 crores. Shareholding as of Sep '25 shows promoters holding 27.1%, with FIIs at 3.7%, DIIs at 14.9%, and public at 54.3%.

As of 7 Dec 2025, Krsnaa Diagnostics share price is ₹750.8. The stock opened at ₹756.5 and had closed at ₹755.9 the previous day. During today’s trading session, Krsnaa Diagnostics share price moved between ₹748.00 and ₹764.25, with an average price for the day of ₹756.13. Over the last 52 weeks, the stock has recorded a low of ₹625.75 and a high of ₹1,033.50. In terms of performance, Krsnaa Diagnostics share price has increased by 11.2% over the past six months and has increased by 10.06% over the last year.